Skip to main content
TipRanks
Go Ultimate75% OFF

Ulys, Llc Insider Profile

4 Followers

Ulys, Llc, Director, Ten Percent Owner at Lexicon Pharmaceuticals, holds 5.55M shares in Lexicon Pharmaceuticals (Ticker: LXRX). Most recently, Ulys, Llc Bought 94,270,206 shares of Lexicon Pharmaceuticals on Mar 19, 2010 for an estimated value of $108.41M.

Ulys, Llc's Trading History

LXRX
Lexicon Pharmaceuticals
Mar 19, 2010Director, Ten Percent OwnerInformative Buy108.41M$9.94M
LXRX
Insider Shares: 5.55M (5.36%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 19, 2010Informative Buy$108.41M94,270,206$1.15+36.90%
Oct 15, 2009Informative Buy$23.18M15,455,145$1.50+12.40%

You May Also Like

Ulys, Llc insider profile FAQ

What is the percentage of profitable transactions made by Ulys, Llc?
The percentage of profitable transactions made by Ulys, Llc is 100%.
What is the average return per transaction made by Ulys, Llc?
The average return per transaction made by Ulys, Llc is 24.60%.
What stocks does Ulys, Llc hold?
Ulys, Llc holds: LXRX stocks.
What was Ulys, Llc’s latest transaction?
Ulys, Llc’s latest transaction was an Informative Buy of $108.41M.
What was Ulys, Llc's most profitable transaction?
Ulys, Llc’s most profitable transaction was an Informative Buy of LXRX stock on March 19, 2010. The return on the trade was 36.90%.
What is Ulys, Llc's role in Lexicon Pharmaceuticals?
Ulys, Llc's role in Lexicon Pharmaceuticals is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.